1. Home
  2. DK vs MLYS Comparison

DK vs MLYS Comparison

Compare DK & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DK
  • MLYS
  • Stock Information
  • Founded
  • DK 2001
  • MLYS 2019
  • Country
  • DK United States
  • MLYS United States
  • Employees
  • DK N/A
  • MLYS N/A
  • Industry
  • DK Integrated oil Companies
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DK Energy
  • MLYS Health Care
  • Exchange
  • DK Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • DK 1.0B
  • MLYS 893.0M
  • IPO Year
  • DK 2006
  • MLYS 2023
  • Fundamental
  • Price
  • DK $15.08
  • MLYS $15.93
  • Analyst Decision
  • DK Sell
  • MLYS Strong Buy
  • Analyst Count
  • DK 10
  • MLYS 3
  • Target Price
  • DK $20.56
  • MLYS $27.00
  • AVG Volume (30 Days)
  • DK 1.6M
  • MLYS 2.1M
  • Earning Date
  • DK 05-06-2025
  • MLYS 05-08-2025
  • Dividend Yield
  • DK 6.69%
  • MLYS N/A
  • EPS Growth
  • DK N/A
  • MLYS N/A
  • EPS
  • DK N/A
  • MLYS N/A
  • Revenue
  • DK $11,852,200,000.00
  • MLYS N/A
  • Revenue This Year
  • DK N/A
  • MLYS N/A
  • Revenue Next Year
  • DK N/A
  • MLYS N/A
  • P/E Ratio
  • DK N/A
  • MLYS N/A
  • Revenue Growth
  • DK N/A
  • MLYS N/A
  • 52 Week Low
  • DK $13.40
  • MLYS $8.24
  • 52 Week High
  • DK $33.60
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • DK 41.15
  • MLYS 59.01
  • Support Level
  • DK $15.38
  • MLYS $16.15
  • Resistance Level
  • DK $16.15
  • MLYS $17.21
  • Average True Range (ATR)
  • DK 0.84
  • MLYS 1.23
  • MACD
  • DK 0.05
  • MLYS -0.10
  • Stochastic Oscillator
  • DK 34.71
  • MLYS 46.83

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: